Spectrum's penny stock takes another hit as CFO quietly plans exit
A little less than 2 months after penny stock player Spectrum Pharmaceuticals took out the budget ax to chop off about a third of its staff, the CFO is now on the way out as well.
In an SEC filing the company reported that Kurt Gustafson is off in search of new opportunities.
There’s no explanation, just the standard:
Mr. Gustafson’s departure is not related to any disagreement with the Company or its auditors on any matter relating to the Company’s financial and accounting operations, policies or practices.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.